Lown J A, Holland P A, Barr A L
Vox Sang. 1984;46(5):300-5. doi: 10.1111/j.1423-0410.1984.tb00090.x.
Complement-binding antibodies (2 examples of anti-Jka and 2 anti-kell) which inhibit agglutination of enzyme-treated cells have been investigated in the sera of 4 patients. The sera containing anti-Jka also contained rhesus antibodies (c + E and D + C) which could not be readily identified by an enzyme technique due to failure of the Jka+ cells of the corresponding Rh phenotype to react. The inhibition of the enzyme test reactivity was revealed using a control reagent added to each test after the initial examination for agglutination. Addition of ethylenediaminetetraacetic acid to the sera prior to testing resulted in identifiable reactivity with panel red cells. Failure to recognise this phenomenon in sera containing antibodies reacting only by an enzyme technique could result in misidentification, delay in providing compatible blood and transfusion of incompatible blood. Routine control of enzyme tests to detect false-negative results is recommended.
对4例患者血清中抑制酶处理细胞凝集的补体结合抗体(2例抗Jka和2例抗Kell)进行了研究。含抗Jka的血清还含有恒河猴抗体(c + E和D + C),由于相应Rh表型的Jka+细胞不发生反应,这些抗体无法通过酶技术轻易鉴定。在初次凝集检查后,向每个试验中添加一种对照试剂,揭示了酶试验反应性的抑制情况。在检测前向血清中加入乙二胺四乙酸,可使与谱细胞发生可识别的反应。在仅通过酶技术反应的抗体血清中未能识别此现象,可能导致错误鉴定、延迟提供相容血液以及输注不相容血液。建议对酶试验进行常规对照以检测假阴性结果。